|
1
|
DeSantis CE, Miller KD, Dale W, Mohile SG,
Cohen HJ, Leach CR, Goding Sauer A, Jemal A and Siegel RL: Cancer
statistics for adults aged 85 years and older, 2019. CA Cancer J
Clin. 69:452–467. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Goding Sauer A,
Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal
A: Colorectal cancer statistics, 2020. CA Cancer J Clin.
70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garza Treviño EN, González PD, Valencia
Salgado CI and Martinez Garza A: Effects of pericytes and colon
cancer stem cells in the tumor microenvironment. Cancer Cell Int.
19:1732019. View Article : Google Scholar
|
|
5
|
Tang M, Wang H, Cao Y, Zeng Z, Shan X and
Wang L: Nomogram for predicting occurrence and prognosis of liver
metastasis in colorectal cancer: A population-based study. Int J
Colorectal Dis. 36:271–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zanconato F, Cordenonsi M and Piccolo S:
YAP and TAZ: A signalling hub of the tumour microenvironment. Nat
Rev Cancer. 19:454–464. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang R, Cai TT, Wu XJ, Liu YN, He J, Zhang
XS, Ma G and Li J: Tumour YAP1 and PTEN expression correlates with
tumour-associated myeloid suppressor cell expansion and reduced
survival in colorectal cancer. Immunology. 155:263–272. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan Y, Tong JHM, Lung RWM, Kang W, Kwan
JSH, Chak WP, Tin KY, Chung LY, Wu F, Ng SSM, et al: RASAL2
promotes tumor progression through LATS2/YAP1 axis of hippo
signaling pathway in colorectal cancer. Mol Cancer. 17:1022018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moon S, Kim W, Kim S, Kim Y, Song Y,
Bilousov O, Kim J, Lee T, Cha B, Kim M, et al: Phosphorylation by
NLK inhibits YAP-14-3-3-interactions and induces its nuclear
localization. EMBO Rep. 18:61–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Felley-Bosco E and Stahel R: Hippo/YAP
pathway for targeted therapy. Transl Lung Cancer Res. 3:75–83.
2014.PubMed/NCBI
|
|
11
|
Tsuji T, Ozasa H, Aoki W, Aburaya S,
Yamamoto Funazo T, Furugaki K, Yoshimura Y, Yamazoe M, Ajimizu H,
Yasuda Y, et al: YAP1 mediates survival of ALK-rearranged lung
cancer cells treated with alectinib via pro-apoptotic protein
regulation. Nat Commun. 11:742020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu S, Zhang Y, Li Q, Zhang Z, Zhao G and
Xu J: CLDN6 promotes tumor progression through the YAP1-snail1 axis
in gastric cancer. Cell Death Dis. 10:9492019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan H, Li H, Li P, Li X, Lin J, Zhu L,
Silva MA, Wang X, Wang P and Zhang Z: Long noncoding RNA MLK7-AS1
promotes ovarian cancer cells progression by modulating
miR-375/YAP1 axis. J Exp Clin Cancer Res. 37:2372018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo L, Chen Y, Luo J, Zheng J and Shao G:
YAP1 overexpression is associated with poor prognosis of breast
cancer patients and induces breast cancer cell growth by inhibiting
PTEN. FEBS Open Bio. 9:437–445. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin MX and Zhang L: Hippo signaling in
epithelial stem cells. Acta Biochim Biophys Sin (Shanghai).
47:39–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park J, Kim GH, Lee J, Phuong BTC, Kong B,
Won JE, Won GW, Lee YH, Han HD and Lee Y: MST2 silencing induces
apoptosis and inhibits tumor growth for estrogen receptor
alpha-positive MCF-7 breast cancer. Toxicol Appl Pharmacol.
408:1152572020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hasegawa K, Fujii S, Matsumoto S, Tajiri
Y, Kikuchi A and Kiyoshima T: YAP signaling induces PIEZO1 to
promote oral squamous cell carcinoma cell proliferation. J Pathol.
253:80–93. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Wang X and Yang Y: Hepatic Hippo
signaling inhibits development of hepatocellular carcinoma. Clin
Mol Hepatol. 26:742–750. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Azar WJ, Christie EL, Mitchell C, Liu DS,
Au-Yeung G and Bowtell DDL: Noncanonical IL6 signaling-mediated
activation of YAP regulates cell migration and invasion in ovarian
clear cell cancer. Cancer Res. 80:4960–4971. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dey A, Varelas X and Guan KL: Targeting
the Hippo pathway in cancer, fibrosis, wound healing and
regenerative medicine. Nat Rev Drug Discov. 19:480–494. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma K, Xu Q, Wang S, Zhang W, Liu M, Liang
S, Zhu H and Xu N: Nuclear accumulation of Yes-associated protein
(YAP) maintains the survival of doxorubicin-induced senescent cells
by promoting survivin expression. Cancer Lett. 375:84–91. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kriz V and Korinek V: Wnt, RSPO and Hippo
signalling in the intestine and intestinal stem cells. Genes
(Basel). 9:202018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kahn M: Can we safely target the WNT
pathway? Nat Rev Drug Discov. 13:513–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Camargo FD, Gokhale S, Johnnidis JB, Fu D,
Bell GW, Jaenisch R and Brummelkamp TR: YAP1 increases organ size
and expands undifferentiated progenitor cells. Curr Biol.
17:2054–2060. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou D, Zhang Y, Wu H, Barry E, Yin Y,
Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD and
Avruch J: Mst1 and Mst2 protein kinases restrain intestinal stem
cell proliferation and colonic tumorigenesis by inhibition of
Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA.
108:E1312–E1320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Wang S, Wang G, Zhang Z, Wu X, Zhang
T, Fu B and Chen G: Yes-associated protein expression is a
predictive marker for recurrence of hepatocellular carcinoma after
liver transplantation. Dig Surg. 31:468–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van Bree C, Franken NA, Snel FA, Haveman J
and Bakker PJ: Wild-type p53-function is not required for
hyperthermia-enhanced cytotoxicity of cisplatin. Int J
Hyperthermia. 17:337–346. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nagashima M, Shiseki M, Pedeux RM, Okamura
S, Kitahama-Shiseki M, Miura K, Yokota J and Harris CC: A novel
PHD-finger motif protein, p47ING3, modulates p53-mediated
transcription, cell cycle control, and apoptosis. Oncogene.
22:343–350. 2003. View Article : Google Scholar : PubMed/NCBI
|
